Tiopronin

Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio.

Tiopronin.

It can be used to improve liver function in patients with chronic hepatitis B.

Follow your doctor's advice.

1. Digestive system: symptoms such as loss of appetite, nausea, vomiting, abdominal pain, diarrhea, etc. may occur occasionally, and abnormal taste is rare. You can reduce the dose or temporarily stop taking it. 2. Allergic reaction: Occasionally itching, rash, skin redness, etc., should stop taking this product. 3. Long-term and large-scale use rarely causes proteinuria or nephrotic syndrome, should reduce the dose or stop taking it. 4. Others: Rare insulin autoimmune syndrome, fatigue and limb numbness should be discontinued.

Patients with a history of allergy to this product are contraindicated.

Not yet clear

Sealed, store in a cool, dry place.

Shandong Luoxin Pharmaceutical Group HENGXIN Pharmaceutical Co., Ltd.

• Founded in:

  2011-04-11

• Address:

  West side of Yanbin Road, Feixian Economic Development Zone

• Tax NO.:

  913713255728813685

• Registered Funds:

  50 million yuan

• Email:

  Log in to view